I'm sorry to hear about your experience. While interstitial lung disease isn't specifically listed as a common side effect of Imbruvica (ibrutinib), it is important to note that targeted therapies, including tyrosine kinase inhibitors like ibrutinib, can sometimes lead to lung complications. Here are some relevant points Show Full Answer

I'm sorry to hear about your experience. While interstitial lung disease isn't specifically listed as a common side effect of Imbruvica (ibrutinib), it is important to note that targeted therapies, including tyrosine kinase inhibitors like ibrutinib, can sometimes lead to lung complications. Here are some relevant points from my knowledge base:

- Common Side Effects of Imbruvica: Fever, fatigue, muscle and bone pain, abnormal bleeding, and low blood cell counts.
- Serious Side Effects: Hypertension, increased risk for infections, dangerous bleeding, cardiac arrhythmias, and tumor lysis syndrome.
- Lung Complications: Targeted therapies can lead to conditions like pleural effusion, pulmonary hypertension, interstitial lung disease, and pneumonia.

Given your symptoms and diagnosis, it might be worth discussing with your healthcare team whether your treatment could be contributing to your condition. Always report any new or worsening symptoms to your doctor.

 This AI-generated response comes from MyLeukemiaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Imbruvica (Ibrutinib) for Leukemia | MyLeukemiaTeam

Heart Problems and Leukemia: Understanding the Connection | MyLeukemiaTeam